154 related articles for article (PubMed ID: 2690331)
1. Relationship between inhibition of acid secretion and healing of peptic ulcers.
Chiverton SG; Hunt RH
Scand J Gastroenterol Suppl; 1989; 166():43-7; discussion 74-5. PubMed ID: 2690331
[TBL] [Abstract][Full Text] [Related]
2. Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.
Jones DB; Howden CW; Burget DW; Kerr GD; Hunt RH
Gut; 1987 Sep; 28(9):1120-7. PubMed ID: 2890561
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole in the management of refractory duodenal ulcer.
Bardhan KD
Scand J Gastroenterol Suppl; 1989; 166():63-73. PubMed ID: 2574910
[TBL] [Abstract][Full Text] [Related]
4. Optimizing acid suppression for treatment of acid-related diseases.
Hunt RH; Cederberg C; Dent J; Halter F; Howden C; Marks IN; Rune S; Walt RP
Dig Dis Sci; 1995 Feb; 40(2 Suppl):24S-49S. PubMed ID: 7859582
[TBL] [Abstract][Full Text] [Related]
5. Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition?
Savarino V; Mela GS; Zentilin P; Celle G
Gastroenterology; 1990 Dec; 99(6):1858-60. PubMed ID: 2227311
[No Abstract] [Full Text] [Related]
6. Medical therapy of peptic ulcer disease.
McQuaid KR; Isenberg JI
Surg Clin North Am; 1992 Apr; 72(2):285-316. PubMed ID: 1347960
[TBL] [Abstract][Full Text] [Related]
7. The correlation between acid suppression and peptic ulcer healing.
Hunt RH; Howden CW; Jones DB; Burget DW; Kerr GD
Scand J Gastroenterol Suppl; 1986; 125():22-31. PubMed ID: 3469740
[TBL] [Abstract][Full Text] [Related]
8. [Omeprazole in peptic ulceration: acid inhibition and endoscopic healing].
Chen SP; Mai CR; Ke MY
Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):720-1, 767. PubMed ID: 2636088
[TBL] [Abstract][Full Text] [Related]
9. Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate, and Maalox.
Johnston DA; Marks IN; Young GO; Tigler-Wybrandi NA; Bridger S; Zak J
Am J Med; 1991 Aug; 91(2A):91S-94S. PubMed ID: 1882910
[TBL] [Abstract][Full Text] [Related]
10. Appropriate acid suppression for optimal healing of duodenal ulcer and gastro-oesophageal reflux disease.
Howden CW; Burget DW; Hunt RH
Scand J Gastroenterol Suppl; 1994; 201():79-82. PubMed ID: 8047830
[TBL] [Abstract][Full Text] [Related]
11. Clinical perspectives of drugs inhibiting acid secretion--H+K+-ATPase inhibitors.
Walan A
Scand J Gastroenterol Suppl; 1986; 125():50-4. PubMed ID: 3029857
[TBL] [Abstract][Full Text] [Related]
12. Is there any acid peptic disease that is refractory to proton pump inhibitors?
Bardhan KD
Aliment Pharmacol Ther; 1993; 7 Suppl 1():13-24, discussion 29-31. PubMed ID: 8490075
[TBL] [Abstract][Full Text] [Related]
13. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
[TBL] [Abstract][Full Text] [Related]
14. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease.
Thomson AB
Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583
[TBL] [Abstract][Full Text] [Related]
15. The effect of 20 Mg omeprazole daily on serum gastrin, 24-h intragastric acidity, and bile acid concentration in duodenal ulcer patients.
Naesdal J; Bankel M; Bodemar G; Gotthard R; Lundquist G; Walan A
Scand J Gastroenterol; 1987 Jan; 22(1):5-12. PubMed ID: 3551048
[TBL] [Abstract][Full Text] [Related]
16. Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment.
Savarino V; Mela GS; Zentilin P; Cutela P; Mansi C; Vassallo A; Franceschi M; Mela MR; Dallorto E; Celle G
Am J Gastroenterol; 1993 Jul; 88(7):1088-92. PubMed ID: 8317411
[TBL] [Abstract][Full Text] [Related]
17. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
18. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression.
Burget DW; Chiverton SG; Hunt RH
Gastroenterology; 1990 Aug; 99(2):345-51. PubMed ID: 2142113
[TBL] [Abstract][Full Text] [Related]
19. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity.
Kato S; Ebina K; Fujii K; Chiba H; Nakagawa H
J Pediatr; 1996 Mar; 128(3):415-21. PubMed ID: 8774516
[TBL] [Abstract][Full Text] [Related]
20. Acid secretory changes and early relapse following duodenal ulcer healing with ranitidine or sucralfate.
Marks IN; Johnston DA; Young GO
Am J Med; 1991 Aug; 91(2A):95S-101S. PubMed ID: 1882911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
